Connection

Jonathan Douxfils to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Jonathan Douxfils has written about Antibodies, Viral.
Jonathan Douxfils
Connection Strength
0.609
Antibodies, Viral
  1. Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021 Sep; 27(9):1351.e5-1351.e7.
    View in: PubMed
    Score: 0.089
  2. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients. Clin Chem Lab Med. 2021 04 27; 59(5):e179-e183.
    View in: PubMed
    Score: 0.087
  3. Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies. Clin Chem. 2020 08 01; 66(8):1104-1106.
    View in: PubMed
    Score: 0.085
  4. The role of serology for COVID-19 control: Population, kinetics and test performance do matter. J Infect. 2020 08; 81(2):e91-e92.
    View in: PubMed
    Score: 0.084
  5. Antibody titres decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021 Dec; 10(1):1495-1498.
    View in: PubMed
    Score: 0.023
  6. Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ. J Infect. 2021 10; 83(4):e4-e5.
    View in: PubMed
    Score: 0.023
  7. Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses. 2021 07 14; 13(7).
    View in: PubMed
    Score: 0.023
  8. Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination. J Infect. 2022 01; 84(1):94-118.
    View in: PubMed
    Score: 0.023
  9. Evaluations of SARS-CoV-2 Serological Assay Performance Need Inclusion of Long-Term Samples. J Clin Microbiol. 2021 05 19; 59(6).
    View in: PubMed
    Score: 0.022
  10. An original multiplex method to assess five different SARS-CoV-2 antibodies. Clin Chem Lab Med. 2021 04 27; 59(5):971-978.
    View in: PubMed
    Score: 0.022
  11. Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins. J Med Virol. 2021 04; 93(4):2262-2269.
    View in: PubMed
    Score: 0.022
  12. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study. Clin Chem Lab Med. 2020 09 25; 58(10):e193-e196.
    View in: PubMed
    Score: 0.021
  13. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies. Clin Biochem. 2020 Dec; 86:23-27.
    View in: PubMed
    Score: 0.021
  14. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med. 2020 Jul 28; 58(8):1357-1364.
    View in: PubMed
    Score: 0.021
  15. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021 02; 93(2):803-811.
    View in: PubMed
    Score: 0.021
  16. Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia. Br J Haematol. 2020 08; 190(4):e187-e189.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.